Article Details

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Price Target Increased to $19.00 by Analysts at ...

Retrieved on: 2021-03-16 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Price Target Increased to $19.00 by Analysts at .... View article details on hiswai:

Excerpt

Renaissance Technologies LLC bought a new position in PhaseBio ... Finally, Platform Technology Partners boosted its holdings in PhaseBio ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up